I was under the impression that we would get the announcement regarding FDA End-Points for the PMS Phase 3 trial before Xmas/New Year.... but I fear that might now be a wrong assumption by me... still time for it before 1 January 2025 hits us!
The tone was that these End-Points were a virtual fait accompli and then it is full steam ahead with phase 3 for PMS, followed by an announcement of the other neurological disorders to be targeted, and then Angelmans Syndrome and Pitt Hopkins Phase 3 Trial planning.
2025 will be the year of NNZ2591.
Ann: Update - Notification of buy-back - NEU, page-76
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$14.20 |
Change
0.890(6.69%) |
Mkt cap ! $1.761B | |||
| Open | High | Low | Value | Volume |
| $13.50 | $14.26 | $12.96 | $9.111M | 655.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $14.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.23 | 3278 | 1 |
View Market Depth
| Last trade - 16.15pm 27/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |